Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review

• প্রধান লেখক: Chinonyerem O. Iheanacho (লেখক), Valentine U. Odili (লেখক), Uchenna I. H. Eze (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: SpringerOpen, 2021-03-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Angiotensin-converting-enzyme-2, being the receptor for SARS-CoV-2, is increased in the use of RAAS inhibitors. Therefore, concerns have been raised over risks of SARS-CoV-2 infection and poor prognosis of COVID-19 in persons with prior exposure to these drugs. This study aimed t...